康复新液联合雷贝拉唑治疗老年消化性溃疡临床效果  

New Recovery Liquid Joint Rabeprazole Azole Treatment of Elderly Peptic Ulcer Clinical Effect

作　　者：程吉云[1] 黄培宁[1] 彭乃宝[1] 姚敦卫 

机构地区：[1]百色市人民医院消化内科,广西百色533000

出　　处：《中外医疗》2015年第20期109-110,共2页China & Foreign Medical Treatment

摘　　要：目的分析观察应用康复新液、雷贝拉唑治疗老年消化性溃疡的临床疗效。方法整群选取2013年5月—2014年7月在该院接受治疗的98例患者作为研究对象,将其随机分为实验组和对照组各49例。给予对照组患者雷贝拉唑进行治疗,给予实验组患者康复新液、雷贝拉唑进行治疗。观察并对比两组患者的治疗效果。结果实验组患者的症状疗效明显优于对照组患者,实验组患者的胃镜疗效明显优于对照组,P<0.05,差异具有统计学意义。结论应用康复新液、雷贝拉唑治疗老年消化性溃疡,效果确切,值得大力推广应用。Objective To analyze and observe the Kangfuxin solution, rabeprazole clinical efficacy in elderly peptic ulcer treatment. Methods 98 patients from May 2013 and July 2014 in our hospitaltreatedfor the studywere randomly divided into experimental and control group 49 cases. Administered to the control group of patients with rabeprazole treatment, rehabilitation of patients in the experimental group to give a new solution, rabeprazole treatment. Observe and compare the therapeutic effect of the two groups of patients. Results Symptoms efficacy of the experimentalgroup weresignificantly better than the control group of patients, the efficacy of the experimental group patients endoscopy was significantly better than the control group, P〈0.05, the difference was statistically significant. Conclusion Rehabilitation of new liquid, rabeprazole treatment of elderly peptic ulcer, the exact effect, worth promoting applications.

关 键 词：雷贝拉唑 康复新液 疗效 老年消化性溃疡 

分 类 号：R59[医药卫生—内科学]